Three patients have just been implanted with a next-generation artificial heart pump called the DuraHeart Left-Ventricular Assist System.

Patients with heart disease who are subsequently diagnosed with depression are at greater risk for heart failure, a condition in which the heart can't pump enough blood throughout the body, according to a new study.

A tiny heart catheter pump which supports the human heart in critical conditions while pumping has been developed.

Researchers have discovered that a prototype drug reduces heart enlargement, one of the most common causes of heart failure. Heart failure, which occurs when the heart can't pump enough blood throughout the body, affects 5 million people in the United States. The condition contributes to 300,000 deaths each year.

An implantable hemodynamic monitor may help to guide medical treatment in a large subgroup of patients with heart failure: those with diastolic heart failure.

Patients taking the common cardiac drug clopidogrel following a heart attack are at a significantly higher risk of a recurrence if they are also taking widely used acid-lowering medications called proton pump inhibitors, a new study has found.

A new study aims to improve the heart's pumping action and help to manage congestive heart failure symptoms. The US PARACHUTE trial tests the effectiveness of placing a small device in the left ventricle, or main pumping chamber of the heart. Physicians recently implanted the sixth person in the United States with the device.

Implantable cardioverter-defibrillators do not appear to be associated with a reduced risk of death in women with advanced heart failure, according to a meta-analysis of previously published research.

A landmark study has successfully demonstrated a 29 percent reduction in heart failure or death in patients with heart disease who received an implanted cardiac resynchronization therapy device with defibrillator (CRT-D) vs. patients who received only an implanted cardiac defibrillator (ICD-only).

People over 80 years of age suffering from a certain type of heart failure do not appear to benefit from most commonly prescribed heart medications, according to a study.